What laboratory tests are conducted for liver cancer?

Liver cancer diagnosis typically involves a combination of laboratory tests designed to assess liver function, detect cancer markers, and support imaging studies. Key tests include:

1. Liver Function Tests (LFTs): These tests measure levels of liver enzymes, bilirubin, and proteins in the blood to evaluate overall liver health. Elevated levels of certain enzymes, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST), can indicate liver damage, although they are not specific to cancer.
2. Alpha-Fetoprotein (AFP) Test: AFP is a protein produced by the liver and its levels can be elevated in patients with liver cancer, especially hepatocellular carcinoma (HCC). This test helps in both diagnosing liver cancer and monitoring treatment response.
3. Hepatitis Virus Tests: Since chronic hepatitis B and C infections are major risk factors for liver cancer, tests for these viruses are crucial. These tests detect viral DNA or RNA and antibodies, helping to assess the infection status and guide management.
4. Genetic and Molecular Tests: Advanced tests may include analyzing genetic mutations and molecular markers specific to liver cancer. These tests can provide information on the cancer’s characteristics and guide personalized treatment approaches.
5. Imaging Studies: While not laboratory tests, imaging techniques like ultrasound, CT scans, and MRI are often used alongside blood tests to confirm the presence of liver cancer and assess its extent.

MyCareLab is leading the way in advancing liver cancer testing through innovative approaches. They offer enhanced AFP assays that provide greater sensitivity and specificity, improving the accuracy of cancer detection and monitoring. MyCareLab also invests in cutting-edge genetic and molecular testing technologies that help identify specific mutations and biomarkers associated with liver cancer. These advancements enable more precise diagnosis and tailored treatment options.

Furthermore, MyCareLab is dedicated to making these advanced tests accessible and affordable, which helps in early detection and effective management of liver cancer. Their focus on innovation and accessibility ensures that patients receive timely and accurate testing, contributing to improved outcomes and better management of liver cancer.